Forschungsverbund Leibniz INFECTIONS
@lfvinfections.bsky.social
Leibniz INFECTIONS ist ein Forschungsverbund der Leibniz-Gemeinschaft
Datenschutz: http://bit.ly/3MeFw2a
Datenschutz: http://bit.ly/3MeFw2a
It is about #globalhealth and #foodsecurity in the context of #climatechange and #socialchange.
👉https://www.leibnizinfections.de/en/news-dates/news/leibniz-infections-at-world-health-summit-in-berlin
👉https://www.leibnizinfections.de/en/news-dates/news/leibniz-infections-at-world-health-summit-in-berlin
October 10, 2025 at 1:44 PM
It is about #globalhealth and #foodsecurity in the context of #climatechange and #socialchange.
👉https://www.leibnizinfections.de/en/news-dates/news/leibniz-infections-at-world-health-summit-in-berlin
👉https://www.leibnizinfections.de/en/news-dates/news/leibniz-infections-at-world-health-summit-in-berlin
Successfully combating #drug-resistant #infections worldwide requires joint efforts from various scientific disciplines and strong political will. In our alliance, 18 participating Leibniz institutes and three external partners are currently working on this challenge in an interdisciplinary manner.
November 24, 2024 at 9:51 AM
Successfully combating #drug-resistant #infections worldwide requires joint efforts from various scientific disciplines and strong political will. In our alliance, 18 participating Leibniz institutes and three external partners are currently working on this challenge in an interdisciplinary manner.
Sahar Saeedi Moghaddam, member of our Alliance, has contributed to the Global Burden of Disease (GBD) 2021 #Antimicrobial #Resistance Report in The Lancet. The study shows that urgent action is needed to improve stewardship, surveillance & efficacy of therapies to mitigate the global #AMR threat.
November 24, 2024 at 8:54 AM
Sahar Saeedi Moghaddam, member of our Alliance, has contributed to the Global Burden of Disease (GBD) 2021 #Antimicrobial #Resistance Report in The Lancet. The study shows that urgent action is needed to improve stewardship, surveillance & efficacy of therapies to mitigate the global #AMR threat.